Skip to main content
BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients
User login
Username
Password
Reset your password
Type
Lead
score